top of page
Lipid Panel
Ordering Recommendation
Use to assess cardiovascular disease risk and guide therapy.
Mnemonic
Methodology
Quantitative Enzymatic Assay
Performed
Mon-Sat
Reported
Within 24 hours
New York DOH Approval Status
This test is New York DOH approved.
Specimen Required
Patient Preparation:
Refer to individual components.
Collect:
Plasma separator tube or serum separator tube.
Specimen Preparation:
Allow serum tube to clot completely at room temperature. Separate serum or plasma from cells within 2 hours of collection. Transfer 1 mL serum or plasma to a standard transport tube. (Min: 0.5 mL)
Storage/Transport Temperature:
Refrigerated
Unacceptable Conditions:
Body fluid (refer to Cholesterol, Fluid; Triglycerides, Fluid; and Chylomicron Screen, Body Fluid).
Remarks:
Stability:
After separation from cells: Ambient: 24 hours; Refrigerated: 7 days; Frozen: 3 months
Reference Interval
Interpretive Data
An HDL cholesterol less than 40 mg/dL is low and constitutes a coronary heart disease risk factor. An HDL cholesterol greater than 60 mg/dL is a negative risk factor for coronary heart disease.
Non-HDL cholesterol is a secondary target of therapy in persons with high serum triglycerides (greater than 199 mg/dL). The goal for non-HDL cholesterol in persons with high triglycerides is 30 mg/dL higher than their LDL cholesterol goal.
CHD Risk Factors
+1 Men, 45 years and older
+1 Women, 55 years and older or premature menopause without estrogen therapy
+1 Family history of premature CHD
+1 Current smoking
+1 Hypertension
+1 Diabetes mellitus
+1 Low HDL cholesterol: 39 mg/dL or less
-1 High HDL cholesterol: 60 mg/dL or greater
Desirable
Adult Values
Higher Risk
Borderline
Total Cholestorol
Triglycerides
199 mg/dL or less
149 mg/dL or less
200-239 mg/dL
150-199 mg/dL
240 mg/dL or greater
200-499 mg/dL
HDL Cholestorol
LDL Cholesterol (calculated)
40 mg/dL or greater
129 mg/dL or less
(99 mg/dL or less if patient has CHD)
39 mg/dL or less
130-159 mg/dL
160 mg/dL or greater
VLDL Cholesterol (calculated)
30 mg/dL or less
Desirable
Children & Adolescents
Higher Risk
Borderline
Total Cholestorol
169 mg/dL or less
170-199 mg/dL
Triglycerides
149 mg/dL or less
150-199 mg/dL
HDL Cholestorol
LDL Cholesterol (calculated)
40 mg/dL or greater
109 mg/dL or less
110-129 mg/dL
VLDL Cholesterol (calculated)
30 mg/dL or less
200 mg/dL or greater
200-499 mg/dL
39 mg/dL or less
130 mg/dL or greater
Note
CPT Code
80061
Components
Component Test Code
0020031
0020040
0020051
0020053
0020551
0020705
0020008
0020023
0020024
0020025
0020027
0020029
0020030
0020032
0020396
3004293
Component Chart Name
Sodium, Serum or Plasma
Potassium, Serum or Plasma
Chloride, Serum or Plasma
Carbon Dioxide, Serum or Plasma
Alkaline Phosphatase
Aspartate Aminotransferase
Alanine Aminotransferase
Urea Nitrogen, Serum or Plasma
Glucose, Serum or Plasma
Creatinine, Serum or Plasma
Calcium, Serum or Plasma
Protein Total, Serum/Plasma
Albumin, Serum or Plasma
Bilirubin, Total, Serum or Plasma
Anion Gap
UH EGFR
LOINC
2951-2
2823-3
2075-0
2028-9
6768-6
1920-8
1742-6
3094-0
2345-7
2160-0
17861-6
2885-2
1751-7
1975-2
33037-3
Aliases
​ACPA Antibody​Anti CitrullineAnti-CCP
C12
Chem 12
Chemistry Panel
Chemistry Screen
CMP
SMA 12
SMA 20
SMAC
​
​
​
bottom of page